Tailored Diabetes Prevention Program for Spanish-Speaking Communities
This study aims to prevent diabetes by evaluating the change in your weight, measured in kilograms, through a tailored program designed specifically for Spanish-speaking communities.
Paso a Paso
Hyperglycemia+2
+ Metabolic Diseases
+ Nutritional and Metabolic Diseases
Prevention Study
Summary
Study start date: July 1, 2025
Actual date on which the first participant was enrolled.The PASO A PASO Pilot Study is a diabetes prevention program specifically tailored for Spanish-speaking communities. This study aims to finalize the 'Paso a Paso' protocol and materials, train a group of 10-15 instructors for the program, and test its feasibility with 30 community participants. The ultimate goal is to gather feedback, refine the intervention, and ensure it resonates with community members, paving the way for a successful larger study. This research is important as it addresses the need for culturally sensitive diabetes prevention programs in Spanish-speaking communities. During the study, participants will engage with the tailored 'Paso a Paso' program, led by trained instructors. The primary outcome measured in this study is the change in participants' weight, which will be recorded in kilograms using a calibrated Tanita WB-100A scale. This measurement helps evaluate the effectiveness of the program in promoting healthier lifestyles and preventing diabetes within the targeted community.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.45 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location